EUVIMEDEUVIMED entdecken
Crossref

Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients

Hanna Kleiboeker, Jillian L Descourouez, Lucas T Schulz, Didier A Mandelbrot, Jon S Odorico, Christopher M Saddler, Jeannina A Smith, Margaret R Jorgenson

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.01.052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Hanna Kleiboeker und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, Wisconsin. Electronic address: hanna.kleiboeker@gmail.com. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Organ Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Virginia Lee Cook Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cytomegalovirus (CMV) infections are common opportunistic infections in solid organ transplants (SOT) with increased health care resource USE and costs. Costs are further increased with ganciclovir-resistance (GR). This study aimed to evaluate the real-world impact of conversion to oral step-down therapy on duration of foscarnet and hospital length of stay (LOS) for treatment of GR-CMV infections in SOT. METHODS: This study included adult recipients of kidney or lung transplants who received foscarnet for genotypically documented GR-CMV while admitted at the University of Wisconsin Hospital from October 1, 2015, to January 31, 2022. Patients in the oral step-down group were converted from standard of care (SOC; foscarnet) to maribavir or letermovir; patients in the historical control group were treated with SOC. RESULTS: Twenty-six patients met the inclusion criteria: 5 in the intervention group and 21 in the SOC group. The median viral load at foscarnet initiation was 11,435 IU/mL. Patients who received oral step-down conversion had shorter mean foscarnet duration than those who received SOC (7 ± 4 vs 37 ± 25 days, P = .017). Mean hospital LOS in the oral step-down group (16 ± 3 days) was shorter than the SOC group (33 ± 21 days; P < .001). In the SOC group, 9 patients lost their graft, and 9 patients died; 2 deaths were attributed to CMV. There were 2 deaths in the oral step-down group, neither of which was attributed to CMV. CONCLUSION AND RELEVANCE: In this real-world case series of patients receiving treatment for GR-CMV infection, oral step-down conversion decreased foscarnet therapy duration and hospital LOS. Future studies are needed to evaluate better the effect of oral step-down in treating GR-CMV infection on treatment duration and cost-savings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsOrgan TransplantationAdultHumansCytomegalovirusFoscarnetAntiviral AgentsGanciclovirTransplant Recipients

Substanzen

FoscarnetAntiviral AgentsGanciclovir

Autor:innen und Institutionen

  • Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, Wisconsin. Electronic address: hanna.kleiboeker@gmail.com.
  • Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
  • Department of Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Department of Surgery, Division of Transplantation, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Department of Medicine, Division of Infectious Diseases, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

Förderung

  • Virginia Lee Cook Foundation

Zitieren

APA

Kleiboeker, H., Descourouez, J. L., Schulz, L. T., Mandelbrot, D. A., Odorico, J. S., Saddler, C. M., Smith, J. A., & Jorgenson, M. R. (2024). Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.01.052

Vancouver

Kleiboeker H, Descourouez JL, Schulz LT, Mandelbrot DA, Odorico JS, Saddler CM, et al. Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.01.052

BibTeX
@article{Kleiboeker2024,
  author = {Kleiboeker, Hanna and Descourouez, Jillian L and Schulz, Lucas T and Mandelbrot, Didier A and Odorico, Jon S and Saddler, Christopher M and Smith, Jeannina A and Jorgenson, Margaret R},
  title = {Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.01.052}
}
Kostenlos starten →